HealthBeacon PLC HealthBeacon - HBCN - Commencement of U.S. Trading on OTCQX

Healthbeacon

31/08/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220831:nRSe6403Xa&default-theme=true

RNS Number : 6403X  HealthBeacon PLC  31 August 2022

HealthBeacon begins trading in the U.S. on OTCQX Market

Dublin, 31 August 2022: HealthBeacon plc ("HealthBeacon" or the "Company"),
the leading digital therapeutics company for managing injectable medications
for patients in the home, today commences trading on the OTCQX® Best Market
in the U.S. under the ticker symbol 'HBCNF'.

The OTCQX is the top tier of the three marketplaces for the over the counter
(OTC) trading of stocks and is operated by the OTC Markets Group. For
companies listed on a qualified international exchange, trading on the OTCQX
facilitates more efficient access to the U.S. financial markets for
HealthBeacon and, through streamlined market standards, enables transparent
trading of the Company's stock for U.S. investors.

"We are very pleased to begin trading on the OTCQX market, an important
milestone for HealthBeacon that provides an opportunity to grow our U.S.
investor base," said HealthBeacon CEO and Co-founder, Jim Joyce.
"Fundamentally, this development enables greater awareness and increased
visibility of our stock in one of our core markets, but we also believe it
will provide improved liquidity and, consequently, enhance shareholder value.
The U.S. is a fast-growing market for HealthBeacon as part of our mission to
become the world's leading platform for managing injectable medications and we
want to continue to build on our success. This is yet another step on our
journey, as a listed business, towards connecting people to better health
through sustainable, digitally enabled solutions," he said.

To qualify for OTCQX, companies must meet high financial standards, follow
best practice corporate governance, and demonstrate compliance with applicable
securities laws.

 Enquiries:
 HealthBeacon:                                    Investor.Relations@HealthBeacon.com

 Laurence Flavin

 Goodbody (Euronext Listing Sponsor and Broker):  +353 (1) 667 0420

 David Kearney
 Stephen Kane

 Drury (Public Relations):
 Cathal Barry                                     +353 (0) 87 227 9281
 Paul Clifford                                    +353 (0)87 327 2161

 

About HealthBeacon PLC

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company
that develops products for managing injectable medications for patients in the
home. The HealthBeacon Injection Care Management System tracks adherence and
persistence with medication schedules through the provision of medication
management reminders, safe and sustainable sharps disposal devices,
educational tools, and artificial intelligence (AI) driven data analytics. The
Company operates across Europe, North America and the United Kingdom and
employs more than 70 people and has obtained more than 30 design and utility
patents. Peer reviewed evidence supports a 19% improvement in therapy
persistence by patients and up to 26% improvement in adherence to therapy,
which improves clinical outcomes and significantly improves efficiency in
health systems. The Company's mission is to become the world's leading digital
therapeutics platform for injectable medications.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading
12,000 U.S. and international securities. Our data-driven disclosure standards
form the foundation of our three public markets: OTCQX® Best Market, OTCQB®
Venture Market and Pink® Open Market.

Our OTC Link® Alternative Trading Systems (ATSs) provide critical market
infrastructure that broker-dealers rely on to facilitate trading.  Our
innovative model offers companies more efficient access to the U.S. financial
markets.

OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS,
operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member
SIPC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISESDLFLSEESELA